Nurosene Health, Ontario Institute for Cancer Research Team for Pancreatic Cancer Research
Nurosene's NetraMark subsidiary will use its AI platform to analyze genome sequencing data from pancreatic cancer patients in order to help personalize treatments.
Canadian Consortium Launches COVID Cloud to Support Molecular Research
Led by DNAstack and supported by Canada's Digital Technology Supercluster, COVID Cloud looks to build a nationwide bioinformatics infrastructure to address the pandemic.
Large-Scale Pan-Cancer Analysis Expands Set of Alterations Disrupting Key Genes, Pathways
Members of a large, international consortium tapped into whole-genome sequences from nearly 2,700 tumors to explore coding and non-coding variants contributing to cancer.
Prostate Cancer Methylation Levels Linked to Regulatory Variants in Germline
Researchers identified variants in the germline that appear to influence DNA methylation levels in prostate cancer tumors or in precancerous tissues.
Cancer-Associated Circular RNAs Catalogued Across Tumor Types
Researchers used exome capture RNA sequencing to come up with a collection of circRNAs in dozens of cancer types, including proposed prostate cancer markers.